EMILY WARBURTON: Open Payments
NPI 1851718258 · CATSKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 39 payments from 9 companies in 2025. Trend: 2023 $843 · 2024 $943 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $198 |
| PFIZER INC. | 12 | $168 |
| GlaxoSmithKline, LLC. | 6 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Exact Sciences Corporation | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, ELIQUIS, Rybelsus, PREVNAR 20, Ozempic, Kerendia, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across NY — which companies pay providers there.
